azacitidine has been researched along with Injury, Ischemia-Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Haese, PC; Godderis, L; Moonen, L; Poels, K; Vervaet, BA | 1 |
| Chiang, HS; Chou, SH; Chung, YC; Huang, BY; Ma, MC | 1 |
2 other study(ies) available for azacitidine and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Untargeted DNA-Demethylation Therapy Neither Prevents Nor Attenuates Ischemia-Reperfusion-Induced Renal Fibrosis.
Topics: Animals; Azacitidine; Collagen Type I; Cytokines; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Enzyme Inhibitors; Fibrosis; Kidney; Kidney Diseases; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Reperfusion Injury; Transforming Growth Factor beta | 2017 |
Protection of bone marrow-derived CD45+/CD34-/lin- stromal cells with immunosuppressant activity against ischemia/reperfusion injury in rats.
Topics: Actinin; Animals; Antigens, CD34; Antigens, Ly; Azacitidine; Bone Marrow Cells; Chemokine CXCL12; Female; Immunosuppression Therapy; Interferon-gamma; Leukocyte Common Antigens; Lymphocytes; Male; Membrane Proteins; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Myocardial Contraction; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Receptors, Transforming Growth Factor beta; Reperfusion Injury; Stromal Cells; Transcription Factors; Transforming Growth Factor beta; Transplantation, Heterologous | 2011 |